The frequency of PDGFRA amplification in lower-grade glioma has only been reported from studies of small numbers of low-grade gliomas36,37, and the evidence was insufficient to reach conclusions about the prognostic value. The gene discussed is PDGFRA; the disease is central nervous system cancer.